Publications Print Frias AL, Stish BJ, Phillips RM, Park SS, Merrell KW, Wilson JM, Waddle MR, Sammon KL, Ward SB, Childs DS, Orme JJ, Quevedo FJ, Johnson GB, Karnes RJ, Kwon ED, Davis BJ. Outcomes of stereotactic body radiotherapy for supraclavicular lymph node metastasis among patients with metastatic prostate cancer. Clin Transl Radiat Oncol. 2026 Jul; 59:101168 Epub 2026 Apr 13 View PubMed Baratz HQ, Hidalgo C, Price DL, Van Abel KM, Lester SC, Routman DM, Wilson J, Baral B, Fuentes Bayne HE, McGarrah PW, Price KR, Yin LX. Neoadjuvant Immunotherapy and Chemoimmunotherapy Regimens in Head and Neck Cancer: A Systematic Review and Meta-Analysis. JAMA Otolaryngol Head Neck Surg. 2026 Mar 12 [Epub ahead of print] View PubMed Grennan K, Singh D, Chindris AM, Wilson J. A patient with hepatocyte nuclear factor 4a maturity-onset diabetes of the young treated with an oral glucagon-like peptide 1 receptor agonist (vol 31 , s88 , 2026). Endocrine Practice. 2026 Feb; 32 (2):295-300 Hobson J.N., Ebner D.K., Ma D.J., Lester S.C., Bayan S., Go R.S., Breen W., Ekbom D.C., Wilson J.M., Malouff T.D., Routman D.M., Neben-Wittich M.A.. Radiation Therapy in Head and Neck Amyloidosis: A 25-Year Institutional Experience International Journal of Radiation Oncology. 2025. Deufel CL, Brost EE, Dupere JM, Wilson JM, Waddle MR, Stish BJ. On the value of an EM tracking quality assurance system for pretreatment verification of needle digitization accuracy in ultrasound-based prostate HDR brachytherapy. Brachytherapy. 2025 May-Jun; 24 (3):450-460 Epub 2025 Feb 17 View PubMed Hall J, Wilson J, Shumway J, Yanagihara TK, Tepper J, Calvo B, Wang AZ, Pearlstein K, Wang K, Kim HJ. Outcomes of surgical resection and intraoperative electron radiotherapy for patients with para-aortic recurrences of gastrointestinal and gynecologic malignancies. Radiat Oncol. 2023 Jun 2; 18 (1):94 Epub 2023 June 02 View PubMed Wilson JM, Davies E, Tan X, Brewster W, Jones E, Weiner AA. Demographic and clinical factors associated with variations in opioid administration using conscious sedation during HDR brachytherapy for cervical cancer. Brachytherapy. 2021 Nov-Dec; 20 (6):1164-1171 Epub 2021 Oct 04 View PubMed Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K, AMPLITUDE-O Trial Investigators. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. N Engl J Med. 2021 Sep 2; 385 (10):896-907 Epub 2021 June 28 View PubMed Wilson JM, Lumley C, Tan X, Shen C, Coniglio A, Weissler M, Yarbrough WG, Hackman T, Blumberg J, Zanation A, Thorp B, Patel SN, Chera BS. Clinical Outcomes of Patients With pT1-T2N0 Oral Tongue Squamous Cell Carcinoma. Am J Clin Oncol. 2021 May 01; 44(5):200-205. View PubMed Wilson JM, Prokop JW, Lorimer E, Ntantie E, Williams CL. Differences in the Phosphorylation-Dependent Regulation of Prenylation of Rap1A and Rap1B. J Mol Biol. 2016 Dec 4; 428 (24 Pt B):4929-4945 Epub 2016 Oct 17 View PubMed Zimmerman NP, Roy I, Hauser AD, Wilson JM, Williams CL, Dwinell MB. Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells. Mol Carcinog. 2015 Mar; 54 (3):203-15 Epub 2013 Sept 24 View PubMed Wilson JM, Lorimer E, Tyburski MD, Williams CL. beta-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells. Cancer Biol Ther. 2015; 16 (9):1364-74 Epub 2015 July 24 View PubMed Schuld NJ, Hauser AD, Gastonguay AJ, Wilson JM, Lorimer EL, Williams CL. SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers. Cell Cycle. 2014; 13 (6):941-52 Epub 2014 Jan 16 View PubMed Zheleznyak A, Wadas TJ, Sherman CD, Wilson JM, Kostenuik PJ, Weilbaecher KN, Anderson CJ. Integrin alpha(v)beta(3) as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. Mol Imaging Biol. 2012 Aug; 14 (4):500-8 View PubMed Shokeen M, Zheleznyak A, Wilson JM, Jiang M, Liu R, Ferdani R, Lam KS, Schwarz JK, Anderson CJ. Molecular imaging of very late antigen-4 (alpha4beta1 integrin) in the premetastatic niche. J Nucl Med. 2012 May; 53 (5):779-86 Epub 2012 Apr 10 View PubMed PST-20538552 Home Publications